Do nutraceutics play a role in the prevention and treatment of colorectal cancer?

By Markle Brian  

Cancer and Metastasis Reviews, Vol. 29, Iss. 3, 2010-09 ,pp. : 395-404

Springer Publishing Company

Access to resources Recommend Favorite

Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear

By Windsor Alastair CJ   Cohen Richard   Jiao Long R   Stebbing Justin  

Future Oncology, Vol. 4, Iss. 6, 2008-12 ,pp. : 741-744

Future Medicine

Access to resources Recommend Favorite

Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the German AIO KRK 0104 trial

By Modest Dominik P.   Laubender Ruediger P.   Stintzing Sebastian   Giessen Clemens   Schulz Christoph   Haas Michael   Mansmann Ulrich   Heinemann Volker  

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 956-962

Informa Healthcare

Access to resources Recommend Favorite

Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer

By Sørbye Halfdan   Berglund Åke   Tveit Kjell Magne   Øgreid Dagfinn   Wanderås Eva Hoff   Wentzel-Larsen Tore   Dahl Olav   Glimelius Bengt  

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 982-988

Informa Healthcare

Access to resources Recommend Favorite

Nordic 5-Fluorouracil/Leucovorin Bolus Schedule Combined with Oxaliplatin (Nordic FLOX) as First-line Treatment of Metastatic Colorectal Cancer

By Sørbye Halfdan   Dahl Olav  

Acta Oncologica, Vol. 42, Iss. 8, 2003-12 ,pp. : 827-831

Informa Healthcare

Access to resources Recommend Favorite